SURAKSHA DIAGNOSTIC Financial Statement Analysis
|
||
|
The Revenues of SURAKSHA DIAGNOSTIC have increased by 23.13% YoY .
The Earnings Per Share (EPS) of SURAKSHA DIAGNOSTIC has increased by 1.15 % YoY. |
||
SURAKSHA DIAGNOSTIC Last 5 Annual Financial Results
[BOM: 544293|NSE : SURAKSHA]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Operating Income | ₹310 Cr | ₹252 Cr | ₹219 Cr | ₹190 Cr | ₹223 Cr |
| Expenses | ₹214 Cr | ₹170 Cr | ₹148 Cr | ₹146 Cr | ₹175 Cr |
| Operating Profit (Excl OI) | ₹96 Cr | ₹82 Cr | ₹71 Cr | ₹44 Cr | ₹48 Cr |
| Other Income | ₹3.16 Cr | ₹3.85 Cr | ₹3.55 Cr | ₹3.55 Cr | ₹2.30 Cr |
| Interest | ₹13 Cr | ₹9.07 Cr | ₹9.61 Cr | ₹9.56 Cr | ₹2.10 Cr |
| Depreciation | ₹41 Cr | ₹35 Cr | ₹33 Cr | ₹32 Cr | ₹15 Cr |
| Profit Before Tax | ₹45 Cr | ₹41 Cr | ₹31 Cr | ₹6.75 Cr | ₹33 Cr |
| Profit After Tax | ₹31 Cr | ₹31 Cr | ₹23 Cr | ₹6.07 Cr | ₹24 Cr |
| Consolidated Net Profit | ₹32 Cr | ₹32 Cr | ₹24 Cr | ₹6.52 Cr | ₹24 Cr |
| Earnings Per Share (Rs) | ₹6.18 | ₹6.11 | ₹342.40 | ₹94.43 | ₹344.20 |
| PAT Margin (%) | 10.12 | 12.29 | 10.57 | 3.19 | 10.64 |
| ROE(%) | 13.81 | 15.93 | 13.93 | 4.01 | 17.40 |
| ROCE(%) | 24.97 | 24.92 | 22.94 | 9.62 | 22.65 |
| Total Debt/Equity(x) | 0.01 | 0.03 | 0.05 | 0.09 | 0.13 |
Key Financials |
||
| Market Cap | : | ₹ 1,557.3 Cr |
| Revenue (TTM) | : | ₹ 325.5 Cr |
| Net Profit(TTM) | : | ₹ 35.1 Cr |
| EPS (TTM) | : | ₹ 6.7 |
| P/E (TTM) | : | 44.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SURAKSHA DIAGNOSTIC | -2.5% | -15.4% | -2.7% |
| APOLLO HOSPITALS ENTERPRISE | -2.1% | -13% | -3.1% |
| MAX HEALTHCARE INSTITUTE | -3.3% | -22.9% | -30.8% |
| FORTIS HEALTHCARE | -2.3% | -19.5% | -33.9% |
| ASTER DM HEALTHCARE | -4.3% | -14.2% | -6.3% |
| NARAYANA HRUDAYALAYA | -4.2% | -12.5% | -4% |
| GLOBAL HEALTH | -4.5% | -20.4% | -14.1% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | -2.8% | -15.7% | -8.8% |
| DR LAL PATHLABS | -0.7% | -3.4% | 16.8% |
SURAKSHA DIAGNOSTIC Revenues
[BOM: 544293|NSE : SURAKSHA]
| Y-o-Y | 23.13 % |
| 5 Yr CAGR | 8.60 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹310 Cr | 23.13 | |
| Mar2025 | ₹252 Cr | 15.26 | |
| Mar2024 | ₹219 Cr | 15.03 | |
| Mar2023 | ₹190 Cr | -14.81 | |
| Mar2022 | ₹223 Cr | - | |
SURAKSHA DIAGNOSTIC Operating Profit
[BOM: 544293|NSE : SURAKSHA]
| Y-o-Y | 17.39 % |
| 5 Yr CAGR | 18.92 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹96 Cr | 17.39 | |
| Mar2025 | ₹82 Cr | 15.59 | |
| Mar2024 | ₹71 Cr | 59.55 | |
| Mar2023 | ₹44 Cr | -7.61 | |
| Mar2022 | ₹48 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -4.68 % |
| 5 Yr CAGR | 9.51 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 30.98% | -4.68 | |
| Mar2025 | 32.5% | 0.28 | |
| Mar2024 | 32.41% | 38.68 | |
| Mar2023 | 23.37% | 8.50 | |
| Mar2022 | 21.54% | - | |
SURAKSHA DIAGNOSTIC Profit After Tax
[BOM: 544293|NSE : SURAKSHA]
| Y-o-Y | 1.14 % |
| 5 Yr CAGR | 7.90 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹32 Cr | 1.14 | |
| Mar2025 | ₹32 Cr | 34.70 | |
| Mar2024 | ₹24 Cr | 262.57 | |
| Mar2023 | ₹6.52 Cr | -72.56 | |
| Mar2022 | ₹24 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -17.66 % |
| 5 Yr CAGR | -1.24 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 10.12 % | -17.66 | |
| Mar2025 | 12.29 % | 16.27 | |
| Mar2024 | 10.57 % | 231.35 | |
| Mar2023 | 3.19 % | -70.02 | |
| Mar2022 | 10.64 % | - | |
SURAKSHA DIAGNOSTIC Earnings Per Share (EPS)
[BOM: 544293|NSE : SURAKSHA]
| Y-o-Y | 1.15 % |
| 5 Yr CAGR | -63.39 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹6.18 | 1.15 | |
| Mar2025 | ₹6.11 | -98.22 | |
| Mar2024 | ₹342 | 262.60 | |
| Mar2023 | ₹94 | -72.57 | |
| Mar2022 | ₹344 | - | |
SURAKSHA DIAGNOSTIC Return on Capital Employed (ROCE)
[BOM: 544293|NSE : SURAKSHA]
| Y-o-Y | 0.20 % |
| 5 Yr CAGR | 2.47 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 24.97% | 0.20 | |
| Mar2025 | 24.92% | 8.63 | |
| Mar2024 | 22.94% | 138.46 | |
| Mar2023 | 9.62% | -57.53 | |
| Mar2022 | 22.65% | - | |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
| Current Share Price | : | ₹298.9 |
| Current MarketCap | : | ₹ 1,557.3 Cr |
| Updated EOD on | : | Oct 23,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SURAKSHA DIAGNOSTIC | -2.5% |
-15.4% |
-2.7% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
SURAKSHA DIAGNOSTIC related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | -2.9% | -9.7% | 5.6% |
| BSE IPO | -5.9% | -8.5% | 4% |
No NSE index found
You may also like the below Video Courses
FAQ about SURAKSHA DIAGNOSTIC Financials
How the annual revenues of SURAKSHA DIAGNOSTIC have changed ?
The Revenues of SURAKSHA DIAGNOSTIC have increased by 23.13% YoY .
How the Earnings per Share (EPS) of SURAKSHA DIAGNOSTIC have changed?
The Earnings Per Share (EPS) of SURAKSHA DIAGNOSTIC has increased by 1.15 % YoY .
Check out Intrinsic Value of Peers of SURAKSHA DIAGNOSTIC
Compare Stock Analytics of Peers of SURAKSHA DIAGNOSTIC
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs FORTIS HEALTHCARE LTD
ASTER DM HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs FORTIS HEALTHCARE LTD
ASTER DM HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
